Medical Device Innovation Consortium Releases Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices

ARLINGTON, Va.–(BUSINESS WIRE)–#MDIC–The Medical Device Innovation Consortium (MDIC) has announced the release of Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices. The report focuses on providing evidence-based best practices for enhancing communication with patients about medical devices so that patients can make informed treatment decisions.

“Patients considering a medical device need to understand the implications of available treatment options. This report helps decision-makers better understand how to communicate in ways that will resonate with patients,” said Scott Goates, PhD, Senior Advisor of Health Economics and Outcomes Research at Abbott and Chair of the Science of Patient Input Communication Working Group. The working group wrote the report on behalf of MDIC’s Science of Patient Input Steering Committee.

A Focus on the Patient’s Perspective

The MDIC report identifies characteristics of providers and patients, and the way in which the scientific and medical information is disseminated, that can affect patients’ comprehension and decision-making.

“The patient perspective that is included in this report will help physicians and medical device manufacturers understand what patients really need,” says heart patient and patient advocate Heidi Dohse. “This report provides patient insights in a way that is actionable for physicians and medical device manufacturers.”

Dohse has been living with pacemakers for 37 years, since she was diagnosed with irregular junctional tachycardia at age 19. Back then, no one told her that there were different types of pacemakers and her first pacemaker wasn’t responsive to her needs as an athlete. Within six months, Dohse had a second procedure to replace her first pacemaker with another pacemaker that was better suited to her needs and goals. Dohse shares her story in the report.

“Patient engagement during the treatment decision-making process is key. This requires that all medical device stakeholders understand how to appropriately communicate with patients about medical devices,” said Pamela Goldberg, MBA, President and CEO of MDIC. “The report is a practical resource that summarizes key terms and provides evidence-based tools, and resources to help develop an effective communication strategy.”

The report is also part of a larger movement to “make sure the patient’s voice is front and center in making decisions about medical devices,” said Goates. That movement includes MDIC’s Science of Patient Input program, which focuses on integrating the patient’s perspective and preferences in the design, clinical development, and regulatory review of innovative medical technologies.

“It’s really important that MDIC is including the patient voice and listening to the patient perspective,” said Dohse.

Read Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices.

Register for the webinar on communicating benefit, risk, and uncertainty for medical devices on Friday, October 2, 2020 at 2 pm ET.

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate the development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives aim to improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market. For more information, visit https://www.mdic.org.

Contacts

Taylor Jackson
tjackson@mdic.org
+1 202.510.9391

Staff

Recent Posts

CBIH: Potential Rescheduling to Schedule III Could Reward Decades of Scientific Preparation and Regulatory Discipline

Houston, Texas--(Newsfile Corp. - December 15, 2025) - Dante Picazo, CEO of Cannabis Bioscience International…

40 minutes ago

Edison Issues Report on discoverIE Group (DSCV)

London, United Kingdom--(Newsfile Corp. - December 15, 2025) - Edison issues report on discoverIE Group…

40 minutes ago

Healthcare IT Market Set to More Than Double by 2030 Growing at 15.24% CAGR, Reports Mordor Intelligence

HYDERABAD, India, December 15, 2025 /PRNewswire/ -- According to Mordor Intelligence, the healthcare IT market …

2 hours ago

Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score

Piramal Pharma Solutions recently achieved a net promoter score (NPS) of 55, far surpassing industry…

2 hours ago

Amphastar Announces FDA Approval for Teriparatide Injection

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)…

2 hours ago

Multi Sciences Elevates Research Access with Global Bioz Badges Roll-out

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 15, 2025 / Bioz, Inc., the leading…

2 hours ago